DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas). More specifically, the invention pertains to the treatment of subjects having a B cell proliferative disorder by...

Full description

Saved in:
Bibliographic Details
Main Authors O´HEAR Carol, Elaine, LI Chi- Chung, BENDER Brendan, Christian
Format Patent
LanguageEnglish
Spanish
Published 25.05.2023
Subjects
Online AccessGet full text

Cover

Loading…